财报披露
Okyo Pharma(OKYO)03-30 02:35
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011937 Act: 34 Size: 92 KB 网页链接
简介：Okyo Pharma Limited在根西岛注册成立。他们是一家临床前生物制药公司，开发下一代疗法，以改善患有炎性眼病和眼部疼痛的患者的生活。他们的研究计划集中在一种新的G蛋白偶联受体（GPCR）上。他们的治疗方法侧重于针对驱动这些疾病的炎症和疼痛调节途径。他们目前正在开发OK-101，这是他们的主要临床前候选产品，用于治疗干眼症。他们还计划评估其对眼神经性疼痛、葡萄膜炎和过敏性结膜炎患者的益处。他们还一直在评估OK-201，一种牛肾上腺髓质，或BAM，一种用于治疗神经性眼痛的脂质肽临床前类似物候选药物，并计划将该候选药物维持在探索水平，同时将公司的主要精力集中在OK-101项目上。
| 今开：1.51 | 昨收：1.55 |
| 最高：1.58 | 最低：1.4639 |
| 涨停价： | 跌停价： |
| 总市值：50518796 |
Okyo Pharma(OKYO)03-30 02:35
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011937 Act: 34 Size: 92 KB 网页链接
Okyo Pharma(OKYO)04-04 18:35
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-013106 Act: 34 Size: 5 MB 网页链接
Okyo Pharma(OKYO)04-09 18:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-013975 Act: 34 Size: 72 KB 网页链接
Okyo Pharma(OKYO)05-08 19:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-018157 Act: 34 Size: 80 KB 网页链接
Okyo Pharma(OKYO)04-02 19:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-012632 Act: 34 Size: 58 KB 网页链接
Okyo Pharma(OKYO)03-21 19:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010725 Act: 34 Size: 55 KB 网页链接
Okyo Pharma(OKYO)03-22 19:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010905 Act: 34 Size: 89 KB 网页链接
Okyo Pharma(OKYO)03-20 20:15
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010618 Act: 34 Size: 51 KB 网页链接
Okyo Pharma(OKYO)04-30 19:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-017143 Act: 34 Size: 65 KB 网页链接
Okyo Pharma(OKYO)02-09 20:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-005557 Act: 34 Size: 52 KB 网页链接查看全文
Okyo Pharma(OKYO)01-31 20:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-004405 Act: 34 Size: 153 KB 网页链接查看全文
Okyo Pharma(OKYO)01-08 20:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-001658 Act: 34 Size: 61 KB 网页链接查看全文
Okyo Pharma(OKYO)01-05 22:35
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-001173 Act: 34 Size: 48 KB 网页链接查看全文
Okyo Pharma(OKYO)2023-12-21 20:45
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-045659 Act: 34 Size: 478 KB 网页链接查看全文
Okyo Pharma(OKYO)2023-12-21 06:35
$Okyo Pharma(OKYO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001493152-23-045624 Act: 33 Size: 769 KB 网页链接查看全文
Okyo Pharma(OKYO)2023-12-19 06:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-045288 Act: 34 Size: 412 KB 网页链接查看全文
Okyo Pharma(OKYO)2023-12-18 19:05
$Okyo Pharma(OKYO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001493152-23-045109 Act: 33 Size: 1 MB 网页链接查看全文
Okyo Pharma(OKYO)2023-12-04 20:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-043499 Act: 34 Size: 53 KB 网页链接查看全文
Okyo Pharma(OKYO)2023-11-29 20:05
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-042992 Act: 34 Size: 5 MB 网页链接查看全文
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-018157 Act: 34 Size: 80 KB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-017143 Act: 34 Size: 65 KB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-013975 Act: 34 Size: 72 KB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-013106 Act: 34 Size: 5 MB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-012632 Act: 34 Size: 58 KB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011937 Act: 34 Size: 92 KB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010905 Act: 34 Size: 89 KB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010725 Act: 34 Size: 55 KB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010618 Act: 34 Size: 51 KB 网页链接
$Okyo Pharma(OKYO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-005557 Act: 34 Size: 52 KB 网页链接